scholarly article | Q13442814 |
P2093 | author name string | Mesut Ogrendik | |
P2860 | cites work | Atherosclerosis and infection: is the jury still not in? | Q22241306 |
Serum antibodies to oral anaerobic bacteria in patients with rheumatoid arthritis | Q24672292 | ||
Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis | Q24813085 | ||
The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy | Q34016674 | ||
Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis | Q34137749 | ||
HLA B27 in health and disease: a double-edged sword? | Q34142454 | ||
Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients | Q34289185 | ||
Atherosclerosis and cardiovascular disease in the spondyloarthritides, particularly ankylosing spondylitis and psoriatic arthritis. | Q38081282 | ||
Structural homologies between two HLA B27-restricted peptides suggest residues important for interaction with HLA B27. | Q43468744 | ||
Association between ankylosing spondylitis and chronic periodontitis: a population-based study | Q43671171 | ||
Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. | Q44068950 | ||
Sulphasalazine in ankylosing spondylitis. A radiological, clinical and laboratory assessment | Q44342666 | ||
Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: a Department of Veterans Affairs cooperative study | Q45334709 | ||
Periodontal disease in patients with ankylosing spondylitis | Q46173445 | ||
Clinical improvement in ankylosing spondylitis with rifamycin SV infiltrations of peripheral joints. | Q54065722 | ||
THE COURSE OF ESTABLISHED ANKYLOSING SPONDYLITIS AND THE EFFECTS OF SULPHASALAZTh OVER 3 YEARS | Q61912643 | ||
A controlled trial of sulphasalazine treatment of chronic ankylosing spondylitis: failure to demonstrate a clinical effect | Q68083745 | ||
Sulphasalazine therapy in ankylosing spondylitis: its effect on disease activity, immunoglobulin A and the complex immunoglobulin A-alpha-1-antitrypsin | Q69374297 | ||
Sulfasalazine in the treatment of ankylosing spondylitis. A twenty-six-week, placebo-controlled clinical trial | Q69924288 | ||
Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study | Q72231863 | ||
Adult periodontitis--specific bacterial infection or chronic inflammation? | Q74342904 | ||
Treatment of ankylosing spondylitis with moxifloxacin | Q80215253 | ||
P433 | issue | 1 | |
P304 | page(s) | 47-49 | |
P577 | publication date | 2015-05-21 | |
P1433 | published in | Current rheumatology reviews | Q27722414 |
P1476 | title | Periodontal pathogens are likely to be responsible for the development of ankylosing spondylitis | |
P478 | volume | 11 |